Epigral Limited (BOM:543332)

Market Cap	63.50B
Revenue (ttm)	24.67B
Net Income (ttm)	4.02B
Shares Out	n/a
EPS (ttm)	93.51
PE Ratio	15.78
Forward PE	15.59
Dividend	6.00 (0.41%)
Ex-Dividend Date	Jun 20, 2025

Volume	855
Average Volume	2,631
Open	1,489.95
Previous Close	1,461.40
Day's Range	1,458.75 - 1,490.00
52-Week Range	1,400.00 - 2,195.85
Beta	n/a
RSI	37.60
Earnings Date	Nov 10, 2025

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agroc...

• Industry: Chemicals and Allied Products
• Founded: 2007
• Employees: 1,072
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543332

Financial Performance

In 2024, Epigral's revenue was 25.50 billion, an increase of 32.19% compared to the previous year's 19.29 billion. Earnings were 3.58 billion, an increase of 82.62%.